Pathogenic variants in ACTN2, coding for alpha-actinin 2, are known to be rare causes of Hypertrophic Cardiomyopathy. However, little is known about the underlying disease mechanisms. Adult heterozygous mice carrying the Actn2 p.Met228Thr variant were phenotyped by echocardiography. For homozygous mice, viable E15.5 embryonic hearts were analysed by High Resolution Episcopic Microscopy and wholemount staining, complemented by unbiased proteomics, qPCR and Western blotting. Heterozygous Actn2 p.Met228Thr mice have no overt phenotype. Only mature males show molecular parameters indicative of cardiomyopathy. By contrast, the variant is embryonically lethal in the homozygous setting and E15.5 hearts show multiple morphological abnormalities. Molecular analyses, including unbiased proteomics, identified quantitative abnormalities in sarcomeric parameters, cell-cycle defects and mitochondrial dysfunction. The mutant alpha-actinin protein is found to be destabilised, associated with increased activity of the ubiquitin-proteasomal system. This missense variant in alpha-actinin renders the protein less stable. In response, the ubiquitin-proteasomal system is activated; a mechanism that has been implicated in cardiomyopathies previously. In parallel, a lack of functional alpha-actinin is thought to cause energetic defects through mitochondrial dysfunction. This seems, together with cell-cycle defects, the likely cause of the death of the embryos. The defects also have wide-ranging morphological consequences.

Department of Physiology Anatomy and Genetics University of Oxford Oxford OX1 3PT UK

Department of Physiology Faculty of Science Charles University 12800 Prague Czech Republic

Department of Structural and Computational Biology Max Perutz Labs University of Vienna 1030 Vienna Austria

Division of Cardiovascular Medicine Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford University of Oxford Oxford OX3 9DU UK

European Molecular Biology Laboratory 38000 Grenoble France

Institute of Cardiovascular Sciences University of Birmingham Birmingham B15 2TT UK

Randall Centre for Cell and Molecular Biophysics King's College London London SE1 9RT UK

School of Basic and Medical Biosciences British Heart Foundation Centre of Research Excellence King's College London London SE1 9RT UK

School of Cardiovascular and Metabolic Medicine and Sciences British Heart Foundation Centre of Research Excellence King's College London London SE1 9RT UK

Transgenic Core Wellcome Centre for Human Genetics University of Oxford Oxford OX3 7BN UK

000      

00000naa a2200000 a 4500

001      

bmc23004109

003      

CZ-PrNML

005      

20230425141111.0

007      

ta

008      

230418s2023 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/cells12050721 $2 doi

035    __

$a (PubMed)36899856

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Broadway-Stringer, Sophie $u Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK

245    10

$a Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2 / $c S. Broadway-Stringer, H. Jiang, K. Wadmore, C. Hooper, G. Douglas, V. Steeples, AJ. Azad, E. Singer, JS. Reyat, F. Galatik, E. Ehler, P. Bennett, JI. Kalisch-Smith, DB. Sparrow, B. Davies, K. Djinovic-Carugo, M. Gautel, H. Watkins, K. Gehmlich

520    9_

$a Pathogenic variants in ACTN2, coding for alpha-actinin 2, are known to be rare causes of Hypertrophic Cardiomyopathy. However, little is known about the underlying disease mechanisms. Adult heterozygous mice carrying the Actn2 p.Met228Thr variant were phenotyped by echocardiography. For homozygous mice, viable E15.5 embryonic hearts were analysed by High Resolution Episcopic Microscopy and wholemount staining, complemented by unbiased proteomics, qPCR and Western blotting. Heterozygous Actn2 p.Met228Thr mice have no overt phenotype. Only mature males show molecular parameters indicative of cardiomyopathy. By contrast, the variant is embryonically lethal in the homozygous setting and E15.5 hearts show multiple morphological abnormalities. Molecular analyses, including unbiased proteomics, identified quantitative abnormalities in sarcomeric parameters, cell-cycle defects and mitochondrial dysfunction. The mutant alpha-actinin protein is found to be destabilised, associated with increased activity of the ubiquitin-proteasomal system. This missense variant in alpha-actinin renders the protein less stable. In response, the ubiquitin-proteasomal system is activated; a mechanism that has been implicated in cardiomyopathies previously. In parallel, a lack of functional alpha-actinin is thought to cause energetic defects through mitochondrial dysfunction. This seems, together with cell-cycle defects, the likely cause of the death of the embryos. The defects also have wide-ranging morphological consequences.

650    _2

$a zvířata $7 D000818

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a myši $7 D051379

650    _2

$a aktinin $x metabolismus $7 D000185

650    12

$a kardiomyopatie $7 D009202

650    12

$a hypertrofická kardiomyopatie $7 D002312

650    _2

$a srdce $7 D006321

650    _2

$a ubikvitiny $7 D014452

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Jiang, He $u Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK

700    1_

$a Wadmore, Kirsty $u Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK

700    1_

$a Hooper, Charlotte $u Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK

700    1_

$a Douglas, Gillian $u Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK $1 https://orcid.org/0000000290905326

700    1_

$a Steeples, Violetta $u Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK

700    1_

$a Azad, Amar J $u Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK $1 https://orcid.org/0000000314727668

700    1_

$a Singer, Evie $u Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK

700    1_

$a Reyat, Jasmeet S $u Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK $1 https://orcid.org/0000000332479186

700    1_

$a Galatik, Frantisek $u Department of Physiology, Faculty of Science, Charles University, 12800 Prague, Czech Republic $1 https://orcid.org/0000000281752604

700    1_

$a Ehler, Elisabeth $u Randall Centre for Cell and Molecular Biophysics, King's College London, London SE1 9RT, UK $u School of Cardiovascular and Metabolic Medicine and Sciences, British Heart Foundation Centre of Research Excellence, King's College London, London SE1 9RT, UK $1 https://orcid.org/0000000156465964

700    1_

$a Bennett, Pauline $u Randall Centre for Cell and Molecular Biophysics, King's College London, London SE1 9RT, UK

700    1_

$a Kalisch-Smith, Jacinta I $u Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK

700    1_

$a Sparrow, Duncan B $u Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, UK $1 https://orcid.org/0000000211416613

700    1_

$a Davies, Benjamin $u Transgenic Core, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK

700    1_

$a Djinovic-Carugo, Kristina $u European Molecular Biology Laboratory, 38000 Grenoble, France $u Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, 1030 Vienna, Austria $1 https://orcid.org/0000000302522972

700    1_

$a Gautel, Mathias $u School of Basic and Medical Biosciences, British Heart Foundation Centre of Research Excellence, King's College London, London SE1 9RT, UK

700    1_

$a Watkins, Hugh $u Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK

700    1_

$a Gehmlich, Katja $u Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK $u Division of Cardiovascular Medicine, Radcliffe Department of Medicine and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK $1 https://orcid.org/0000000340191844

773    0_

$w MED00194911 $t Cells $x 2073-4409 $g Roč. 12, č. 5 (2023)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36899856 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230418 $b ABA008

991    __

$a 20230425141108 $b ABA008

999    __

$a ok $b bmc $g 1924648 $s 1190318

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 12 $c 5 $e 20230224 $i 2073-4409 $m Cells $n Cells $x MED00194911

GRA    __

$p Wellcome Trust $2 United Kingdom

GRA    __

$p British Heart Foundation $2 United Kingdom

LZP    __

$a Pubmed-20230418